Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
pharmaphorum
32m
Lilly gets second approval, in Japan, for Alzheimer's drug
Kisunla (donanemab) is the second in a new generation of amyloid-targeting medicines to reach the Japanese market after Eisai ...
Pharmaceutical Technology
44m
MHLW approves Eli Lilly’s Kinsula to treat Alzheimer’s in Japan
Eli Lilly has received approval in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Woman dies in 'suicide pod’
Food packaging cancer risk
Haitian group files complaint
‘Trump Train’ jury verdict
Penn suspends law professor
Phoenix breaks heat record
US to waive visas for Qatar
Rioter mistakenly released
Executed by lethal injection
X account hacked
Partners with Google
Johnny Cash statue unveiled
Dali owner, operator sued
Pac-12 sues Mountain West
PA county ballot ruling
Severe obesity on the rise
NC sending absentee ballots
EEOC blocked on rules
ISR: Hezbollah leader killed
Retiring after 14 seasons
Recalls 41K+ motorcycles
InfoWars to be auctioned off
Calls strike against 'LoL’
Pres candidates' security bill
NYC schools boss retiring
$375M military aid to UKR
Union gets more voting time
AZ campaign office damaged
Related topics
Japan
S&P 500 Index
Novo Nordisk
Alzheimer's disease
Kisunla
Feedback